Schneeberger Daniel — SEC insider filings

SEC reporting owner CIK 1861120. 26 insider filings on record with FilingPulse; latest filed 2026-11-13.

Transaction summary — filings shown

Covers all 26 filings on record, filed 2025-04-11 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Keros Therapeutics, Inc. (KROS)10% owner45 legs · 934,258 sh · $9,464,5123 legs · 5,389,264 sh · $95,659,43612
TENAX THERAPEUTICS, INC. (TENX)10% owner410 legs · 3,619,049 sh · $6,263,483——
Rallybio Corp (RLYB)10% owner414 legs · 302,473 sh · $4,229,263——
NextCure, Inc. (NXTC)10% owner519 legs · 374,631 sh · $1,852,320——
InMed Pharmaceuticals Inc. (MTRI)10% owner920 legs · 627,775 sh · $961,474——

Insider filings — Schneeberger Daniel

FiledFormIssuerReported transactionsSource
2026-11-134NextCure, Inc. (NXTC)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 12,333 @ $5.10EDGAR
2026-11-094NextCure, Inc. (NXTC)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 1,024 @ $5.10 · Purchase (P): 3,662 @ $5.10EDGAR
2026-11-094InMed Pharmaceuticals Inc. (MTRI)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 2,640 @ $13.10EDGAR
2026-10-274InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 4 @ $1.32EDGAR
2026-10-274NextCure, Inc. (NXTC)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 5,626 @ $4.83 · Purchase (P): 1,672 @ $5.03 · Purchase (P): 3,553 @ $5.10EDGAR
2026-10-214TENAX THERAPEUTICS, INC. (TENX)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 336,528 @ $1.51 · Purchase (P): 254,342 @ $1.60 · Purchase (P): 331,979 @ $1.66EDGAR
2026-10-204InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 1 @ $1.32 · Purchase (P): 1,086 @ $1.32EDGAR
2026-10-154InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 564 @ $1.33 · Purchase (P): 8,021 @ $1.33 · Purchase (P): 984 @ $1.32EDGAR
2026-10-084InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 5,601 @ $1.33 · Purchase (P): 3,046 @ $1.33 · Purchase (P): 2,256 @ $1.33EDGAR
2026-10-054InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 16,431 @ $1.33 · Purchase (P): 8,307 @ $1.33 · Purchase (P): 18,182 @ $1.33EDGAR
2026-09-164InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 28,505 @ $1.29 · Purchase (P): 54,256 @ $1.30 · Purchase (P): 8,340 @ $1.29EDGAR
2026-09-084TENAX THERAPEUTICS, INC. (TENX)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 900,000 @ $1.78EDGAR
2026-09-024TENAX THERAPEUTICS, INC. (TENX)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 403,571 @ $1.79 · Purchase (P): 179,058 @ $1.80 · Purchase (P): 187,704 @ $1.80EDGAR
2026-08-244TENAX THERAPEUTICS, INC. (TENX)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 202,124 @ $1.78 · Purchase (P): 716,369 @ $1.77 · Purchase (P): 107,374 @ $1.75EDGAR
2026-08-034NextCure, Inc. (NXTC)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 50,000 @ $4.97 · Purchase (P): 20,000 @ $5 · Purchase (P): 20,000 @ $5 · Purchase (P): 25,000 @ $4.81 · Purchase (P): 100,000 @ $4.90 · Purchase (P): 77,850 @ $4.96 · +3 moreEDGAR
2026-07-294NextCure, Inc. (NXTC)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 7,798 @ $5.00 · Purchase (P): 6,400 @ $4.95 · Purchase (P): 1,810 @ $5 · Purchase (P): 1,600 @ $5EDGAR
2026-07-174InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 1,000 @ $1.55EDGAR
2026-05-214InMed Pharmaceuticals Inc. (INM)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 68,551 @ $1.60 · Purchase (P): 200,000 @ $1.56 · Purchase (P): 200,000 @ $1.50EDGAR
2026-05-204Rallybio Corp (RLYB)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 6,009 @ $13.98 · Purchase (P): 10,000 @ $13.98 · Purchase (P): 200 @ $13.80EDGAR
2026-05-154Rallybio Corp (RLYB)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 4,081 @ $13.80 · Purchase (P): 75,178 @ $14 · Purchase (P): 100 @ $13.80 · Purchase (P): 200 @ $13.95EDGAR
2026-05-134Rallybio Corp (RLYB)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 5,100 @ $14.00 · Purchase (P): 25,000 @ $14 · Purchase (P): 19,900 @ $14 · Purchase (P): 800 @ $13.83EDGAR
2026-05-064Rallybio Corp (RLYB)
jointly with ADAR1 Capital Management, LLC
Purchase (P): 3,900 @ $13.90 · Purchase (P): 116,904 @ $13.97 · Purchase (P): 35,101 @ $14.00EDGAR
2025-10-154Keros Therapeutics, Inc. (KROS)
jointly with ADAR1 Capital Management, LLC, ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC
Sale (S): 4,391,237 @ $17.75 · Sale (S): 254,669 @ $17.75 · Sale (S): 743,358 @ $17.75EDGAR
2025-06-244Keros Therapeutics, Inc. (KROS)
jointly with ADAR1 Capital Management, LLC, ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC
Option exercise/expiry (X): 100 @ $60 · Option exercise/expiry (X): 1,400 @ $70 · Option exercise/expiry (X): 200 @ $70 · Option exercise/expiry (X): 1 (derivative) @ $0 · Option exercise/expiry (X): 14 (derivative) @ $0 · Option exercise/expiry (X): 2 (derivative) @ $0EDGAR
2025-06-124Keros Therapeutics, Inc. (KROS)
jointly with ADAR1 Capital Management, LLC, ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC
Code (E): 300 (derivative) @ $0 · Code (E): 836 (derivative) @ $0 · Code (E): 178 (derivative) @ $0EDGAR
2025-04-114Keros Therapeutics, Inc. (KROS)
jointly with ADAR1 Capital Management, LLC, ADAR1 Partners, LP, ADAR1 Capital Management GP, LLC
Purchase (P): 18,560 @ $9.40 · Purchase (P): 16,365 @ $9.40 · Purchase (P): 325,000 @ $9.86 · Purchase (P): 500,000 @ $10.33 · Purchase (P): 74,333 @ $10.33 · Other (J): 325,000 (derivative) · +2 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861120 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs